Simultaneous islet–kidney vs pancreas–kidney transplantation in type 1 diabetes mellitus: a 5 year single centre follow-up
- 1 November 2007
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 51 (1) , 110-119
Abstract
Aims/hypothesis The aim of this study was to compare the long-term outcomes—in terms of glucose control, renal function and procedure-related complications—of simultaneous islet–kidney (SIK) transplantation with those of simultaneous pancreas–kidney (SPK) transplantation in patients with type 1 diabetes mellitus. Methods HbA1c, need for insulin, GFR and complication rate were compared between 13 recipients of SIK and 25 recipients of SPK transplants at the same institution. The mean follow-up was 41 months. Results Two primary organ non-functions occurred in the SIK group. HbA1c did not differ at any time point during follow-up in the SIK group compared with the SPK group (mean during follow-up 6.3 vs 5.9%). Similarly, kidney function over time was not different between the two groups. A higher rate of insulin independence following SPK transplantation (after 1 year 96 vs 31% in the SIK group) was counterbalanced by a higher rate of serious adverse events (40% relaparotomies vs 0% in the SIK group). Conclusions/interpretation The endogenous insulin production achieved by islet transplantation, combined with optimal insulin therapy, was sufficient for maintaining near-normal glucose levels. In terms of glucose control, islet transplantation provides results comparable to those achieved with pancreas transplantation. However, SPK results in a higher rate of insulin independence, albeit at the cost of more surgical complications. These results have led to a new paradigm in islet transplantation at our institution, where the primary goal is not insulin independence, but good glucose control and avoidance of severe hypoglycaemia.Keywords
This publication has 28 references indexed in Scilit:
- International Trial of the Edmonton Protocol for Islet TransplantationNew England Journal of Medicine, 2006
- Sirolimus in Combination with Tacrolimus Is Associated with Worse Renal Allograft Survival Compared to Mycophenolate Mofetil Combined with TacrolimusAmerican Journal of Transplantation, 2005
- Spectrum of surgical complications after simultaneous pancreas–kidney transplantation in a prospectively randomized study of two immunosuppressive protocolsNephrology Dialysis Transplantation, 2005
- Mortality Assessment for Pancreas TransplantsAmerican Journal of Transplantation, 2004
- β-Cell Function and the Development of Diabetes-Related Complications in the Diabetes Control and Complications TrialDiabetes Care, 2003
- THE IMPACT OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION ON LONG-TERM PATIENT SURVIVAL1Transplantation, 2001
- Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation.2000
- Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failureThe Lancet, 1999
- A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction EquationAnnals of Internal Medicine, 1999
- Effects of Pancreas Transplantation on Postprandial Glucose MetabolismNew England Journal of Medicine, 1991